Most importantly, we discovered that TRRAP harbored a recurrent mutation that clustered in one position (p. Ser722Phe) in 6 out of 167 affected individuals (&#8764;4%), as well as a previously unidentified gene, GRIN2A, which was mutated in 33% of melanoma samples.
C0025202
melanoma